| __timestamp | MannKind Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79383000 | 7751000 |
| Thursday, January 1, 2015 | 108402000 | 10251000 |
| Friday, January 1, 2016 | 46928000 | 9575000 |
| Sunday, January 1, 2017 | 74959000 | 10912000 |
| Monday, January 1, 2018 | 79716000 | 11049000 |
| Tuesday, January 1, 2019 | 74669000 | 11646000 |
| Wednesday, January 1, 2020 | 59040000 | 13265000 |
| Friday, January 1, 2021 | 77417000 | 25805000 |
| Saturday, January 1, 2022 | 91473000 | 35182000 |
| Sunday, January 1, 2023 | 94314000 | 94999000 |
Unlocking the unknown
In the competitive world of biotechnology, managing operational costs is crucial for success. MannKind Corporation and Viridian Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, MannKind consistently reported higher Selling, General, and Administrative (SG&A) expenses, peaking in 2015 with a 38% increase from the previous year. In contrast, Viridian's SG&A expenses grew steadily, culminating in a dramatic 270% surge in 2023, nearly matching MannKind's expenses for the first time. This shift highlights Viridian's aggressive expansion strategy, while MannKind's fluctuating expenses suggest a more volatile approach. Understanding these trends provides valuable insights into each company's operational efficiency and strategic priorities. As the biotech landscape evolves, monitoring SG&A efficiency will be key to predicting future market leaders.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Viatris Inc. and MannKind Corporation
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or MannKind Corporation
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: MannKind Corporation vs Travere Therapeutics, Inc.
MannKind Corporation and Novavax, Inc.: SG&A Spending Patterns Compared